Renal function in pediatric patients with beta-thalassemia major

B Aldudak1, A Karabay Bayazit, A Noyan

  • 1Department of Pediatrics, Cukurova University School of Medicine, Balcali, Adana, Turkey.

Insights

Beta-thalassemia major patients experience organ failure from iron overload. This study reveals proximal renal tubular damage in children with beta-thalassemia major, linked to oxidative stress from iron deposits.

Area of Science:

  • Nephrology
  • Pediatrics
  • Hematology

Background:

  • Beta-thalassemia major is a severe inherited blood disorder.
  • Iron overload from chronic transfusions is a primary cause of morbidity and mortality.
  • Organ damage, particularly kidney injury, significantly impacts patient outcomes.

Purpose of the Study:

  • To investigate the nature of kidney injury in children with beta-thalassemia major.
  • To identify potential pathogenetic factors contributing to renal damage.
  • To assess markers of proximal tubular dysfunction and oxidative stress.

Main Methods:

  • Comparative study involving 70 children with beta-thalassemia major and 14 healthy controls.
  • Collection and analysis of blood and timed urine samples.
  • Hematological and biochemical tests including BUN, serum creatinine, electrolytes, uric acid, and specific tubular markers (UP/Cr, UNAG/Cr, UMDA/Cr, TRP).

Main Results:

  • No significant differences in standard renal function markers (BUN, creatinine, creatinine clearance) between groups.
  • Statistically significant differences observed in serum potassium, phosphorus, uric acid, urine volume, and tubular markers (UP/Cr, UNAG/Cr, UMDA/Cr, TRP).
  • Elevated serum potassium, phosphorus, and uric acid attributed to erythrocyte turnover; elevated UP/Cr, UNAG/Cr, UMDA/Cr suggest proximal tubular damage.

Conclusions:

  • Children with beta-thalassemia major exhibit proximal renal tubular damage.
  • This damage is likely secondary to oxidative lipid peroxidation mediated by iron overload.
  • Monitoring tubular function and oxidative stress markers is crucial for managing beta-thalassemia major patients.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.